- 5.14.2025
- News
- Updates
- Press Releases
Press Release: Veterans Exploring Treatment Solutions (VETS) Leads Legislative Day of Action in Support of AB 1103 at California State Capitol
VETS Advocacy Campaign Expands to California as Efforts for Access to Life-Changing Mental Health Treatments Continue
- 5.5.2025
- News
- Press Releases
PRESS RELEASE: Veterans Exploring Treatment Solutions (VETS) Announces 4th Annual Torchbearer Ball to End Veteran Suicide
On November 15, 2025, the 4th Annual Torchbearer Ball returns to the iconic Hotel del Coronado. Hosted by Veterans Exploring Treatment Solutions (VETS), this black-tie gala gathers 600+ guests to honor veteran advocates, raise vital funds for psychedelic-assisted therapies, and advance the mission to end veteran suicide. This year’s Torchbearer Award will recognize filmmakers Jon Shenk and Bonni Cohen for their documentary In Waves and War, highlighting the healing journeys of Special Operations veterans.
- 10.31.2025
- News
International Documentary Association: Producer's Diary: 'In Waves and War'
In this behind-the-scenes peek, filmmakers Bonni Cohen, Jon Shenk, and Jessica Anthony detail the production and impact pivots of their Participant-funded feature, 'In Waves and War.'
- 10.30.2025
- News
California governor signs bill to promote state psychedelics research
Governor Gavin Newsom has signed California Assembly Bill 1103, a landmark law to accelerate psychedelic research—particularly focused on mental health, traumatic brain injury, and substance use disorder. Sponsored by VETS, the bill aims to benefit veterans and others by streamlining research approvals for substances like psilocybin, ibogaine, and MDMA. Amber Capone called it “a pivotal moment” for science and mental health. The law doesn’t legalize psychedelics but clears a path for responsible, expedited studies that prioritize veterans’ well-being.
- 10.22.2025
- News
DoubleBlind: Farewell Dr. Nolan Williams, Pioneer of Psychedelic Medicine
Dr. Nolan Williams, Who Helped Bring Ibogaine Research Into the Mainstream, Dies at 42 At Stanford, he pushed the boundaries of brain-stimulation and psychedelic science, advancing ibogaine research and reshaping how psychiatry approaches healing.